New Drug Daraxonrasib Significantly Improves Survival for Cancer Patients
A groundbreaking new drug has nearly doubled survival rates for patients with advanced pancreatic cancer, targeting the mutated KRAS gene and offering hope where standard treatments fall short.
Admin
June 1, 2026
